CETUXIMAB
cetuximab 100 mg/20 mL injection, 20 mL vial
CETUXIMAB (4436L)
4436L
Manner of administration:Injection
Restriction 12045
Indication: Metastatic colorectal cancer
Treatment phase: Initial treatment
Restriction 4908
Indication: Metastatic colorectal cancer
Treatment phase: Initial treatment
Quantities & Cost
| Max amount | # of repeats | DPMA | Max safety net | General Patient Charge |
|---|---|---|---|---|
| Max amount: 1100 mg | # of repeats: 0 | DPMA: $3,045.00 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | ||||
| Erbitux
(cetuximab 100 mg/20 mL injection, 20 mL vial)
|
||||
| Erbitux
(cetuximab 500 mg/100 mL injection, 100 mL vial)
|
||||